People with rare diseases would get better health insurance coverage for their medicines.
This bill would make it easier for people with rare diseases to get their medications covered by Medicare, Medicaid, and private insurance. It would expand what counts as a 'medically accepted' use for these drugs. It would also create a faster way to appeal coverage denials. These changes would take effect starting January 1, 2027.
Today, coverage for drugs treating rare diseases under Medicare and Medicaid might be limited. This is because their use isn't always explicitly approved or listed in certain standard guides. Private insurance plans also lack a required fast appeal process for these denials. If this bill becomes law, starting January 1, 2027, Medicare and Medicaid would cover more rare disease drugs. This coverage would be based on peer-reviewed research or expert opinion. Private plans would also need to offer a quicker way to appeal denials.
S 3551 · 119th Congress · December 17, 2025 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
2 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.